glp-1/gcgr dual agonist GLP-1-based therapies for type 2 diabetes: from single, and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Discovery of novel OXM-based glucagon-like
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14


























